Why is Transgene Biotek falling/rising?

As of 10-Nov, Transgene Biotek Ltd's stock price is currently at 3.84, reflecting an increase of 0.33 or 9.4%. The stock has shown a positive performance today, outperforming its sector by 10.98% and has been on a consecutive gain for the last two days, accumulating a total return of 13.27% during this period. However, despite this recent uptick, the stock has experienced a significant decline year-to-date of 43.78% and a 1-month drop of 7.69%. The stock's delivery volume has decreased by 2.05% compared to the 5-day average, indicating a falling investor participation, which may temper the positive momentum. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Transgene Biotek's short-term return of +1.05% over the past week contrasts with the Sensex, which has declined by 0.53% during the same period. This indicates that the stock is performing better than the benchmark in the short term. However, when looking at the longer-term performance, the stock has underperformed significantly compared to the Sensex, which has gained 6.91% year-to-date. This disparity highlights the challenges faced by Transgene Biotek in maintaining investor confidence despite recent gains.